Riparian LLC is a solutions provider for the pharmaceuticals/life sciences industry, offering consulting, outsourcing, and software. Founded in 2016, Riparian is comprised of a team with diverse backgrounds specializing in pharmaceutical pricing, rebate analysis, business consulting, and engineering. The company aims to assist clients in navigating the increasingly regulated industry through strategic planning and outcome evaluation. Bolstered by the support of the Envision Pharma Group, Riparian benefits from cutting-edge technology and artificial intelligence solutions, medical strategy, medical communications, publication planning & delivery, and patient engagement services. Additionally, the company provides access to Envision Pharma Group's proprietary services through Okra.ai, Two Labs, and 90TEN. The emergence of regulations within the industry has heightened the demand for partners who can offer targeted guidance and support. Riparian's expertise allows them to empower clients through innovative solutions, delivering efficient, clear, and accelerated insights. With a focus on objectivity and key results, Riparian is equipped to assist clients with a laser-like focus on their objectives.
There is no investment information
No recent news or press coverage available for Riparian LLC.